The Biogenerics Market Outlook

In the coming decade, dozens of blockbuster biotech treatments will come off patent. That will not only create a huge savings for patients and insurers, but it will create enormous opportunities for generic drug manufacturers worldwide. We'll explain the implications and identify some of the ways you can benefit.

Everyone is familiar with generic drugs that were once proprietary. As soon as the patent runs out, companies rush in with their version of a popular drug.

But so far, biotech medicines have.....